TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ORKA

Oruka Therapeutics, Inc.

Healthcare · Biotechnology

97.70$ +4.5% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Oruka Therapeutics, Inc. (ORKA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 489 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ORKA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
16 40 25 12 6.8 8.5 50 55 43 38 396 489
15 39 21 12 6.8 8.5 50 54 43 38 377 344
15 39 7.4 8.7 6.6 8.4 49 53 42 37 62 47
15 39 21 12 6.6 8.4 49 53 42 37 376 337
1.4 1.5 2.4 2.1 0.8 0.9 3.9 3.9 1.4 0.8 14 17
1.4 1.5 2.4 2.1 0.8 0.9 3.5 3.5 1.1 0.6 13 15
0.0 0.0 0.1 0.1 0.1 0.2 0.6
0.6 0.2 0.4 1.8 1.1 0.3 3.5 4.2
15 38 22 10 6.0 7.6 47 51 42 37 382 472
-85 -96 -113 -131 -139 -144 -154 -173 -183 -189 -84 -189
0.0 0.0 0.0 0.0 0.1 0.1 4.7 14 14 14 17 46

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?